Cargando…
Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility
Leukocyte immunoglobulin-like receptor A3 (LILRA3) is a soluble immune regulatory molecule primarily expressed by monocytes and macrophages. A homozygous 6.7kbp LILRA3 gene deletion that removes the first seven of its eight exons is predicted to lead to lack of LILRA3 protein, although this has not...
Autores principales: | An, Hongyan, Lim, Chai, Guillemin, Gilles J., Vollmer-Conna, Ute, Rawlinson, William, Bryant, Katherine, Tedla, Nicodemus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752247/ https://www.ncbi.nlm.nih.gov/pubmed/26871720 http://dx.doi.org/10.1371/journal.pone.0149200 |
Ejemplares similares
-
LILRA2 Selectively Modulates LPS-Mediated Cytokine Production and Inhibits Phagocytosis by Monocytes
por: Lu, Hao K., et al.
Publicado: (2012) -
Correction: LILRA2 Selectively Modulates LPS-Mediated Cytokine Production and Inhibits Phagocytosis by Monocytes
por: Lu, Hao K., et al.
Publicado: (2012) -
LILRA3 is related to monocyte-derived dendritic cell maturation and activation
por: Wu, Xinyu, et al.
Publicado: (2021) -
Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome
por: Argyriou, Evangelia, et al.
Publicado: (2021) -
Association of the LILRA3 Deletion with B-NHL and Functional Characterization of the Immunostimulatory Molecule
por: Low, Hui Zhi, et al.
Publicado: (2013)